Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - CA
$ 1.14
-0.87 %
$ 144 M
Market Cap
-3.35
P/E
1. INTRINSIC VALUE
Balance Sheet
OrganiGram Holdings Inc.
| Current Assets | 262 M |
| Cash & Short-Term Investments | 108 M |
| Receivables | 37.2 M |
| Other Current Assets | 118 M |
| Non-Current Assets | 146 M |
| Long-Term Investments | 40.7 M |
| PP&E | 96.2 M |
| Other Non-Current Assets | 8.68 M |
| Current Liabilities | 53.3 M |
| Accounts Payable | 47.1 M |
| Short-Term Debt | 1.09 M |
| Other Current Liabilities | 5.14 M |
| Non-Current Liabilities | 48.5 M |
| Long-Term Debt | 3.37 M |
| Other Non-Current Liabilities | 45.2 M |
EFFICIENCY
Earnings Waterfall
OrganiGram Holdings Inc.
| Revenue | 160 M |
| Cost Of Revenue | 112 M |
| Gross Profit | 47.5 M |
| Operating Expenses | 83.2 M |
| Operating Income | -35.7 M |
| Other Expenses | 9.77 M |
| Net Income | -45.4 M |
RATIOS
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
OrganiGram Holdings Inc.
| Net Income | -45.4 M |
| Depreciation & Amortization | 12.1 M |
| Capital Expenditures | -5.34 M |
| Stock-Based Compensation | 7.18 M |
| Change in Working Capital | 15 M |
| Others | 42.1 M |
| Free Cash Flow | -1.47 M |
Wall Street Analysts Price Targets
OrganiGram Holdings Inc.
OGI has no price targets from Wall Street.
4. DIVIDEND
ANALYSIS
OGI does not distribute dividends.
5. COMPETITION
6. Ownership
Insider Ownership
OrganiGram Holdings Inc.
Sold
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
0 USD 0
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
| Date | Value | Insider | Amount | Avg Price |
|---|
7. News
Cannabis Producer Organigram Q1 Sales Jump 17%, Expect C$10 Million From Motif Integration, Annual Run-Rate Synergies Within Two Years
On Tuesday, Cannabis producer Organigram Holdings Inc OGI reported first-quarter 2025 gross sales of CA$66.8 million, up 19% year-over-year, beating the consensus of CA$65.4 million.
benzinga.com
- 2 weeks ago
Organigram Holdings Inc. (OGI) Q1 2025 Earnings Call Transcript
Organigram Holdings Inc. (NASDAQ:OGI ) Q1 2025 Earnings Conference Call February 11, 2025 8:00 AM ET Company Participants Max Schwartz - Director of IR Beena Goldenberg - CEO Greg Guyatt - CFO Conference Call Participants Aaron Grey - Alliance Global Partners Yewon Kang - Canaccord Genuity Operator Good morning. My name is Krista, and I will be your conference operator today.
seekingalpha.com
- 2 weeks ago
OrganiGram (OGI) Reports Q1 Loss, Lags Revenue Estimates
OrganiGram (OGI) came out with a quarterly loss of $0.05 per share versus the Zacks Consensus Estimate of a loss of $0.03. This compares to loss of $0.14 per share a year ago.
zacks.com
- 2 weeks ago
Organigram Reports First Quarter Fiscal 2025 Results
TORONTO--(BUSINESS WIRE)--Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), a leading licensed producer of cannabis, announced its results for the first quarter ended December 31, 2024 (“Q1 Fiscal 2025”). The Q1 Fiscal 2025 results include the financial results of Motif Labs Ltd. ("Motif") from December 6, 2024 to December 31, 2024, following the Company's acquisition of Motif. Q1 FISCAL 2025 HIGHLIGHTS Net revenue increased 17% to $42.7 million from $36.5 mill.
businesswire.com
- 2 weeks ago
Organigram to Report First Quarter Fiscal 2025 Results on February 11, 2025
TORONTO--(BUSINESS WIRE)--Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (together, the “Company” or “Organigram”), a leading licensed producer of cannabis, announced today it will report earnings results for its first quarter fiscal 2025 ended December 31, 2024, on Tuesday, February 11, 2025, prior to market open. The Company will host a conference call to discuss its results with details as follows: Date: Tuesday, February 11, 2025 Time: 8:00 am Easte.
businesswire.com
- 3 weeks ago
Organigram: Long Term Growth Improving With International And Domestic Cannabis Expansion (Rating Upgrade)
Organigram reported Q4-2024 financial results earlier this week and show improved revenues, profit margins, net loss, and increased cash. The company announced the acquisition of Canadian private cannabis LP Motif Labs which will set Organigram in the top spot in Canada by market share. Organigram has increased its international footprint with an investment in Sanity Group in Germany and in Open Book Extracts in the US.
seekingalpha.com
- 2 months ago
Organigram Holdings Inc. (OGI) Q4 2024 Earnings Call Transcript
Organigram Holdings Inc. (NASDAQ:OGI ) Q3 2024 Earnings Conference Call December 18, 2024 8:00 AM ET Company Participants Max Schwartz - Director of IR Beena Goldenberg - CEO Tim Emberg - CCO Greg Guyatt - CFO Conference Call Participants Aaron Grey - Alliance Global Partners Frederico Gomes - ATB Capital Markets Pablo Zuanic - Zuanic & Associates Yewon Kang - Canaccord Genuity Operator Good morning. My name is Rob, and I will be your conference operator today.
seekingalpha.com
- 2 months ago
Canada's Organigram shops for U.S. pot businesses with backing from British American Tobacco
Legal cannabis company grows revenue and narrows its loss as it continues its acquisition push.
marketwatch.com
- 2 months ago
Organigram Reports Fourth Quarter and Fiscal 2024 Results
TORONTO--(BUSINESS WIRE)--Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), a leading licensed producer (“LP”) of cannabis, announced its results for the fourth quarter and twelve months ended September 30, 2024 (“Q4 Fiscal 2024” or “Fiscal 2024”). All financial information in this press release is expressed in Canadian dollars (“$”). Comparable Periods: The Company's results for Q4 Fiscal 2024 and Fiscal 2024 reflect the three-month and 12-month periods ended.
businesswire.com
- 2 months ago
Organigram to Report Fourth Quarter and Fiscal 2024 Results on December 18, 2024
TORONTO--(BUSINESS WIRE)--Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (together, the “Company” or “Organigram”), a leading licensed producer of cannabis, announced today it will report earnings results for its fourth quarter and fiscal 2024 ended September 30, 2024, on Wednesday, December 18, 2024, prior to market open. The Company will host a conference call to discuss its results with details as follows: Date: Wednesday, December 18, 2024 Time: 8:0.
businesswire.com
- 2 months ago
OrganiGram purchasing Motif Labs to become Canada's largest cannabis company by market share, as others retreat
OrganiGram to pay up to C$100 million ($70.7 million) for vape and prerolled cannabis specialist Motif.
marketwatch.com
- 2 months ago
Organigram Acquires Motif, Becoming Canada's Largest Cannabis Company by Market Share
TORONTO--(BUSINESS WIRE)--Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the "Company" or "Organigram"), a leading licensed producer of cannabis, is pleased to announce the acquisition of 100% of the issued and outstanding shares of Motif Labs Ltd. (“Motif”), for upfront consideration of $90 million, consisting of $50 million in cash and $40 million of Organigram common shares priced based on the 30 day trading VWAP of $2.3210 on the Toronto Stock Exchange (“TSX”). In addition, Motif share.
businesswire.com
- 2 months ago
8. Profile
Summary
OrganiGram Holdings Inc. OGI
COUNTRY
CA
INDUSTRY
Drug Manufacturers - Specialty & Generic
MARKET CAP
$ 144 M
Dividend Yield
0.00%
Description
Organigram Holdings Inc., through its subsidiaries, produces and sells cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including cannabis flowers, cannabis oils, and vaporizers for civilian patients and veterans; adult use recreational cannabis under the Edison Cannabis Co., Trail Blazer, SHRED, SHRED'ems, Big Bag O' Buds, and Monjour brands; and cannabis edibles products and concentrates. The company also engages in the wholesale shipping of cannabis plant cuttings, dried flowers, blends, pre-rolls, and cannabis derivative based products to retailers and wholesalers for adult-use recreational cannabis. It sells its products through online, as well as telephone channels. Organigram Holdings Inc. was founded in 2013 and is headquartered in Moncton, Canada.
Contact
35 English Drive, Moncton, NB, E1E 3X3
https://www.organigram.ca
IPO
Date
May 21, 2019
Employees
1093
Officers
Ms. Beena G. Goldenberg
Chief Executive Officer & Director
Mr. Greg Guyatt C.A., CPA
Chief Financial Officer
Mr. Timothy Emberg
Chief Commercial Officer
Mr. Paolo De Luca C.A., C.F.A
Chief Strategy Officer
Mr. Geoffrey John Riggs
Chief Information Officer
Ms. Katrina May McFadden
Chief People Officer
Ms. Helen Martin
Chief Legal Officer & Corporate Secretary
Max Schwartz
Director of Investor Relations
Mr. Gregory Engel
Special Advisor
Ms. Nathalie Batten Kubrick
Senior Vice President of Operations